Oral administration of Lactobacillus fermentum CRL1446 improves biomarkers of metabolic syndrome in mice fed a high-fat diet supplemented with wheat bran.
- 2021-03-23
- Clinical Trial · n = 6
- Food & Function 11(5)
- R. Medina
- Matías Russo
- Antonela Marquez
- Héctor M. Herrera
- M. C. Abeijón-Mukdsi
- L. Saavedra
- E. Hebert
- Paola Gauffin-Cano
- PubMed: 32421119
- DOI: 10.1039/d0fo00730g
- Low evidence
- Animal Study
On the other hand, L. fermentum CRL1446 reduced fasting glucose and insulin levels, improving the HOMA index in mice with MS.
- Beneficial
- Large effect